AssuranceSelect 7 Plus with MVA (Truist) review

For the right buyer, yes. This is a solid 7-year accumulation FIA backed by one of the strongest carriers in the annuity market. The 7-year cap-lock strategy gives buyers an uncommon degree of rate certainty, and the optional income rider means you're not forced to pay for income protection you may not need.

The "depends" caveat matters here: if you live in California or New York, this product isn't available to you. If you're not already a Truist client or don't have access to a Truist advisor, you can't buy it. And if there's a meaningful chance you'll need your money before the seven years are up, the combination of surrender charges and MVA creates a real cost for early exit that shouldn't be ignored.

The main reason is the carrier quality paired with the cap-lock feature. MassMutual Ascend's A++ rating means a buyer can commit to a 7-year contract with a high degree of confidence that the company will be standing at the end of it. The 7-year S&P 500 cap-lock strategy locks in an index cap for the entire surrender period — if caps fall in years three or four, you're still earning under the rate you locked at the start. That's a meaningful difference from standard annual-reset designs where the company can lower caps at each reset.

The optional Income Ascender rider adds a second reason: someone who is not yet sure whether they want income protection can defer that decision. The 9% simple-interest roll-up on the benefit base over a 10-year accumulation period is competitive, and the rider can be added without committing to it at contract issue (verify with your advisor — terms should be confirmed before purchase).

I think this annuity works best for a Truist client in the 55-75 age range with seven-plus years before they expect to tap this money, a preference for guaranteed principal protection over market risk, and an interest in index-linked growth without equity downside. The $10,000 minimum makes it accessible at smaller account sizes compared to some FIA competitors.

It's less appealing for someone who prioritizes liquidity above return, lives in California or New York, wants a purely accumulation-focused contract without any income rider infrastructure, or is shopping the open market for the strongest FIA crediting rates available.

You're not buying direct stock market exposure. A fixed indexed annuity credits interest based on index performance, but your principal is protected from index losses — you won't lose money due to index declines. The tradeoff is that upside is capped. The caps and participation rates define the ceiling on what you can earn in any given crediting period.

What distinguishes AssuranceSelect 7 Plus with MVA from a basic FIA is the 7-year cap-lock strategy. In most FIAs, the carrier resets cap rates at each renewal period — typically annually. Here, the S&P 500 7-year cap-lock strategy sets a guaranteed cap for the entire 7-year surrender period. That transforms the usual uncertainty about future crediting terms into a known quantity from day one, which matters a lot for buyers who want to know what they're committing to.

The product offers four indexed strategies plus a declared rate account. The annual strategies include S&P 500 point-to-point with cap, iShares U.S. Real Estate ETF (IYR) point-to-point with cap, and SPDR Gold Shares point-to-point with cap. All use 100% participation with annual caps ranging from 7.00% to 11.50% as of the March 2026 rate sheet — those figures will change at reset.

The headline strategy is the S&P 500 7-year cap lock. This strategy measures annual S&P 500 point-to-point performance each year, but the cap rate applied to those measurements is locked at contract issue for the full 7-year surrender period. If the carrier lowers caps in the broader market over those seven years, buyers in this strategy are insulated. That's the core structural advantage. The declared rate strategy was offering 4.05%–4.30% as of March 2026, functioning more like a fixed annuity for buyers who prefer predictable credited interest over index variability.

The optional Income Ascender rider — a Guaranteed Lifetime Withdrawal Benefit — is the secondary feature worth understanding even if you're not sure you'll use it. The rider accumulates a benefit base using a 9% simple interest roll-up per year during the first 10 years (or until the benefit base equals 250% of premiums paid, whichever comes first). At activation, lifetime withdrawals are drawn against that benefit base for life, regardless of how the underlying account value performs.

The 1.10% annual fee (current; maximum 2.50%) on the benefit base is real, and it's deducted from contract value — not the benefit base. Whether that fee is worth it depends on your withdrawal timeline and payout rate at your activation age. For buyers who plan to activate income within 7-12 years, the math can be favorable. For buyers who want pure accumulation, skipping the rider avoids the fee entirely.

The 7-year surrender schedule starts at 8% and steps down: 8%, 8%, 7%, 6%, 5%, 4%, 3%, then free. That's a relatively front-weighted schedule — the first two years carry identical 8% charges, which is worth noting for anyone who might reconsider in year two.

The free-withdrawal provision is standard for the FIA market: 10% of purchase payments in year one, then 10% of account value from year two onward. Required minimum distributions are available without surrender charges for qualified accounts, which makes this workable inside an IRA for most holders.

The MVA — Market Value Adjustment — is the added complexity. It works in both directions: when interest rates rise after you buy, the MVA can increase your surrender cost above the stated schedule. When rates fall, it can actually reduce it. In a rising-rate environment, the combination of a stated 6% charge in year five plus a negative MVA could make an early exit materially more expensive than the surrender table alone implies. The MVA applies to withdrawals exceeding the free-withdrawal amount during the 7-year period and drops away entirely after year seven.

There are also waiver provisions: the Terminal Illness Waiver Rider and Extended Care Waiver Rider can suspend withdrawal charges under qualifying circumstances (not available in all states).

There is no disclosed base contract fee in the available materials — this is a low-confidence field in the source documents, so confirm with your Truist advisor whether any annual administrative charge applies.

The only explicit fee is for optional riders. The Income Ascender (GLWB) runs 1.10% annually on the benefit base, with a contractual maximum of 2.50%. If you also add the optional Inheritance Enhancer II death benefit rider, that adds another 1.15% annually on its benefit base. Layering both riders brings the annual fee load to 2.25% at current rates on a combined base — meaningful, especially against the cap-limited upside of the indexed strategies.

Without riders, the product's cost is structural rather than explicit: upside is capped, and the MVA creates exit-cost risk. For buyers who add no riders, the tradeoff is cap limits in exchange for principal protection and a cap-lock guarantee on the 7-year S&P 500 strategy.

Legal Entity: MassMutual Ascend Life Insurance Company

Parent: Massachusetts Mutual Life Insurance Company

A.M Best Rating: A++

MassMutual Ascend is the annuity-focused subsidiary of MassMutual, one of the oldest and most financially stable life insurers in the United States. The A++ rating from A.M. Best is the highest category available and reflects exceptional financial strength. For a 7-year commitment, carrier stability matters — and this is one of the stronger carriers in the FIA market on that dimension.